160 related articles for article (PubMed ID: 32345242)
1. Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome.
Freytag M; Herrlinger U; Hauser S; Bauernfeind FG; Gonzalez-Carmona MA; Landsberg J; Buermann J; Vatter H; Holderried T; Send T; Schumacher M; Koscielny A; Feldmann G; Heine M; Skowasch D; Schäfer N; Funke B; Neumann M; Schmidt-Wolf IGH
BMC Cancer; 2020 Apr; 20(1):355. PubMed ID: 32345242
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
Engelhardt M; Ihorst G; Schumacher M; Rassner M; Gengenbach L; Möller M; Shoumariyeh K; Neubauer J; Farthmann J; Herget G; Wäsch R
BMC Cancer; 2021 Feb; 21(1):173. PubMed ID: 33596881
[TBL] [Abstract][Full Text] [Related]
3. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Pillay B; Wootten AC; Crowe H; Corcoran N; Tran B; Bowden P; Crowe J; Costello AJ
Cancer Treat Rev; 2016 Jan; 42():56-72. PubMed ID: 26643552
[TBL] [Abstract][Full Text] [Related]
4. Validation of team performance assessment of multidisciplinary tumor boards.
Jalil R; Akhter W; Lamb BW; Taylor C; Harris J; Green JS; Sevdalis N
J Urol; 2014 Sep; 192(3):891-8. PubMed ID: 24631109
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.
Nemesure B; Albano D; Bilfinger T
Cancer Epidemiol; 2020 Oct; 68():101804. PubMed ID: 32896806
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands.
Walraven JEW; Desar IME; Hoeven van der JJM; Aben KKH; Hillegersberg van R; Rasch CRN; Lemmens VEPP; Verhoeven RHA
Eur J Cancer; 2019 Nov; 121():85-93. PubMed ID: 31563730
[TBL] [Abstract][Full Text] [Related]
7. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
[TBL] [Abstract][Full Text] [Related]
8. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.
Kesson EM; Allardice GM; George WD; Burns HJ; Morrison DS
BMJ; 2012 Apr; 344():e2718. PubMed ID: 22539013
[TBL] [Abstract][Full Text] [Related]
9. [COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie].
Grosclaude P; Azria D; Guimbaud R; Thibault S; Daubisse-Marliac L; Cartron G; Renaudie MJ; Dalbies PA; Delord JP; Bauvin E
Bull Cancer; 2020; 107(7-8):730-737. PubMed ID: 32425210
[TBL] [Abstract][Full Text] [Related]
10. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study.
Vermeulen BD; Bruggeman L; Bac DJ; Schrauwen RWM; Epping LSM; Scheffer RCH; Tan ACITL; Groenen MJM; Verhoeven RHA; Siersema PD
Acta Oncol; 2020 Apr; 59(4):410-416. PubMed ID: 32067535
[No Abstract] [Full Text] [Related]
11. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):739-47. PubMed ID: 14529779
[TBL] [Abstract][Full Text] [Related]
12. Impact of optional multidisciplinary tumor board meeting on the mortality of patients with gastrointestinal cancer: A retrospective observational study.
Basendowah M; Awlia AM; Alamoudi HA; Ali Kanawi HM; Saleem A; Malibary N; Hijazi H; Alfawaz M; Alzahrani AH
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1373. PubMed ID: 33739628
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapy.
Zerini D; Patti F; Spada F; Fazio N; Pisa E; Pennacchioli E; Prestianni P; Cambria R; Pepa M; Grana CM; Bonomo G; Funicelli L; Jereczek-Fossa BA; Orecchia R
Tumori; 2021 Apr; 107(2):145-149. PubMed ID: 32734835
[TBL] [Abstract][Full Text] [Related]
14. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
15. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.
Ung KA; Campbell BA; Duplan D; Ball D; David S
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e298-304. PubMed ID: 24674013
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
[TBL] [Abstract][Full Text] [Related]
17. Impact of treatment sequence of multimodal therapy for advanced oral cavity cancer with mandible invasion.
Myers LL; Sumer BD; Truelson JM; Nedzi L; Perkins S; Hughes RS; Ahn C
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):961-6. PubMed ID: 21810773
[TBL] [Abstract][Full Text] [Related]
18. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
[TBL] [Abstract][Full Text] [Related]
19. A second expert pathology review of cutaneous melanoma in multidisciplinary meetings: Impact on treatment decisions.
Palve JS; Ylitalo LK; Luukkaala TH; Jernman JM; Korhonen NJ
Surg Oncol; 2019 Sep; 30():72-75. PubMed ID: 31500789
[TBL] [Abstract][Full Text] [Related]
20. Tumor boards and the quality of cancer care.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; Shulman LN; McNeil BJ
J Natl Cancer Inst; 2013 Jan; 105(2):113-21. PubMed ID: 23274388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
